Huma, the “Shopify of digital health,” raised $80 million in Series D funding

Huma, a UK-based healthcare AI company, has recently secured $80 million in Series D funding, bringing its total funding raised to over $300 million. This substantial investment underscores Huma's pivotal role in advancing digital health solutions globally. The company specializes in developing modular platforms used by more than 3,000 hospitals and clinics worldwide. These platforms serve over 35 million screened users and support 4 million registered users in healthcare settings. Huma's technology has also facilitated over 800 studies, engaging approximately 1 million participants in medical research.

Huma's technological capabilities include a range of virtual care tools such as digital-first screening, population health initiatives, and remote patient monitoring (RPM) solutions at scale. They also provide companion apps designed to assist patients through treatment regimens and drug therapies, as well as digital clinical trial solutions, including decentralized trials, which accelerate medical research processes.

The company is actively involved in major national healthcare projects across various countries, including the US, UK, Germany, Greece, and Saudi Arabia. Huma collaborates closely with leading pharmaceutical companies globally, enhancing its impact and reach in the healthcare sector.

In conjunction with its Series D funding, Huma has launched the Huma Cloud Platform. This ecosystem supports not only Huma's own digital health initiatives but also empowers external entities to efficiently launch and scale their healthcare projects. The platform aims to streamline the development and deployment of digital health solutions, potentially reducing the timeline from years to just a few days. Huma has achieved regulatory clearances such as FDA Class II, EuMDR Class IIb, and Saudi FDA Class C for its platform, enabling rapid and code-free configuration with integration of AI and machine learning models. This regulatory status minimizes costs, time, and risks associated with digital health project development.

The Series D funding round attracted participation from both new and existing strategic and financial investors, including entities like AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures, and Leaps by Bayer. These partnerships underscore industry confidence in Huma's vision and technological capabilities. Dan Vahdat, Founder and CEO of Huma, describes the Huma Cloud Platform as analogous to Shopify for digital health, aiming to democratize access to advanced digital and AI technologies across all economic strata. By scaling digital and AI solutions, Huma aims to transition medicine from reactive to proactive, making healthcare more affordable and consistent globally.

Huma has collaborated with tech giants like Google to develop advanced AI models, enhancing the capabilities of its Cloud Platform. Features such as the "10x Nurse" demonstrate Huma's commitment to automating administrative tasks in patient care, thereby increasing efficiency and scalability in healthcare delivery.

Looking ahead, Huma plans to leverage its Huma Cloud Platform and next-generation AI models to expand its impact in digital-first care and research initiatives. The platform's Software Development Kit (SDK) will enable startups and enterprises to integrate similar functionalities into their existing solutions, fostering innovation and scalability in the healthcare industry.

In summary, Huma's Series D funding and the launch of the Huma Cloud Platform signify a significant leap towards revolutionizing digital health solutions globally. With robust technological infrastructure, strategic partnerships, and a commitment to innovation, Huma is poised to drive substantial advancements in healthcare delivery and medical research in the years to come.